How many insider declarations has Kenyon Lawrence A filed?

Kenyon Lawrence A has filed 2 public insider declarations with SEC (Form 4).

What is Kenyon Lawrence A's role?

Kenyon Lawrence A's reported role is not specified by the regulator across the filings.

Which companies does Kenyon Lawrence A report trades for?

Kenyon Lawrence A reports trades for Outlook Therapeutics, Inc..

What is Kenyon Lawrence A's declared buy vs sell volume?

Across the available history, declared buys total 25k€ and disposals 0.

← Executives ★ Sign in to follow

KL

Kenyon Lawrence A

CFO

·SEC (Form 4)

Outlook Therapeutics, Inc.

0

Total declarations

0

Company

€25,450

▲ Purchases (2 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

2

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Discover the full record of transactions filed by Kenyon Lawrence A. Director active across 1 company, notably Outlook Therapeutics, Inc.. Cumulatively, 2 filings have been published. Split: 2 buys · 0 sell. Total volume traded: €25k. History available since 26 September 2024. The latest transaction was filed on 26 September 2024 (Acquisition). Regulator: SEC (Form 4). All data is free.

Companies and markets linked to Kenyon Lawrence A

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Outlook Therapeutics, Inc. (US)

Declarations2 total

▲

KENYON LAWRENCE A

Chief Financial OfficerExecutives14 Aug 2026Outlook Therapeutics, Inc.

0SEC ↗

101,010 sharesCommon StockSEC:0001649989-26-000009:0

Canonical exit: 12 Nov 2026 (T+90)

▲

KENYON LAWRENCE A

Chief Financial OfficerExecutives26 Sept 2024Outlook Therapeutics, Inc.

$28,44631SEC ↗

5,000 shares@ US$5.6892100.0% of flowCommon StockSEC:0001415889-24-024093:0

Canonical exit: 25 Dec 2024 (T+90)

2 of 2 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

KL

Kenyon Lawrence A

CFO

·SEC (Form 4)

Outlook Therapeutics, Inc.

0

Total declarations

0

Company

€25,450

▲ Purchases (2 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

2

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Discover the full record of transactions filed by Kenyon Lawrence A. Director active across 1 company, notably Outlook Therapeutics, Inc.. Cumulatively, 2 filings have been published. Split: 2 buys · 0 sell. Total volume traded: €25k. History available since 26 September 2024. The latest transaction was filed on 26 September 2024 (Acquisition). Regulator: SEC (Form 4). All data is free.

Companies and markets linked to Kenyon Lawrence A

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Outlook Therapeutics, Inc. (US)

Declarations2 total

▲

KENYON LAWRENCE A

Chief Financial OfficerExecutives14 Aug 2026Outlook Therapeutics, Inc.

0SEC ↗

101,010 sharesCommon StockSEC:0001649989-26-000009:0

Canonical exit: 12 Nov 2026 (T+90)

▲

KENYON LAWRENCE A

Chief Financial OfficerExecutives26 Sept 2024Outlook Therapeutics, Inc.

$28,44631SEC ↗

5,000 shares@ US$5.6892100.0% of flowCommon StockSEC:0001415889-24-024093:0

Canonical exit: 25 Dec 2024 (T+90)

2 of 2 declarations

Kenyon Lawrence A

Insider track record

Companies and markets linked to Kenyon Lawrence A

Related entities

Kenyon Lawrence A

Insider track record

Companies and markets linked to Kenyon Lawrence A

Related entities